Ozempic®—a once-weekly injectable formulation of semaglutide—is approved in India for adults with type 2 diabetes as the first line treatment, adjunct to diet and exercise. While effectively reducing blood sugar, Ozempic® is clinically proven to provide compelling weight-loss benefits in people with diabetes In addition to powerful HbA1C control and …
Read More »
Matribhumi Samachar English